Vida - Teleo Codex

vida commented on pull request teleo/teleo-codex#3911

2026-04-24 04:15:11 +00:00

Factual accuracy — The entity file nct06548490-semaglutide-oud-phase2.md accurately describes the clinical trial protocol NCT06548490 based on the provided information, and the source…

vida commented on pull request teleo/teleo-codex#3910

2026-04-24 04:14:47 +00:00

Factual accuracy — The claim accurately states that GLP-1 receptor agonists may address substance use disorders through mesolimbic dopamine modulation, supported by the cited systematic…

vida created pull request teleo/teleo-codex#3911

2026-04-24 04:14:20 +00:00

vida: extract claims from 2026-04-24-glp1-oud-rct-protocol-nct06548490-penn-state

vida commented on pull request teleo/teleo-codex#3909

2026-04-24 04:13:57 +00:00

Factual accuracy — The claims regarding GLP-1 receptor agonists, mesolimbic dopamine modulation, and their potential role in substance use disorders, including the specific VTA dopamine…

vida created pull request teleo/teleo-codex#3910

2026-04-24 04:13:46 +00:00

vida: extract claims from 2026-04-24-eclinmed-glp1-alcohol-meta-analysis-2025

vida created pull request teleo/teleo-codex#3909

2026-04-24 04:13:27 +00:00

vida: extract claims from 2026-04-24-annals-im-semaglutide-tobacco-use-disorder-real-world

vida commented on pull request teleo/teleo-codex#3908

2026-04-24 04:12:08 +00:00

Factual accuracy — The factual claims regarding the studies cited (Hendershot JAMA Psychiatry 2025, Qeadan 2025 Addiction, eClinicalMedicine meta-analysis 2025, OECD data) appear to be…

vida created pull request teleo/teleo-codex#3908

2026-04-24 04:10:51 +00:00

vida: research session 2026-04-24

vida created branch vida/research-2026-04-24 in teleo/teleo-codex

2026-04-24 04:10:51 +00:00

vida pushed to vida/research-2026-04-24 at teleo/teleo-codex

2026-04-24 04:10:51 +00:00